Literature DB >> 23262977

Health care resource utilization in untreated HIV-infected children in a pediatric programme, Abidjan, Côte d'Ivoire, 2004-2009.

Sophie Desmonde1, Patrick A Coffie, Edmond A Aka, Clarisse Amani-Bosse, Eugène Messou, François Dabis, Andrea Ciaranello, Valériane Leroy.   

Abstract

BACKGROUND: We describe health care resource utilization among HIV-1-infected children who have not yet undergone antiretroviral treatment (ART) in Abidjan, Côte d'Ivoire.
METHODS: HIV-infected children enrolled prospectively in an HIV care programme in 2 health facilities in Abidjan (2004-2009) were followed up from date of inclusion until database closeout, death, ART initiation, or loss to follow-up (no clinical contact for more than 6 months). Incidences of health care resource utilization (outpatient care, inpatient day care, and hospitalization) were described according to severe morbidity and mixed effect log linear models were computed to identify associated factors.
RESULTS: Overall, 405 children were included, entering care at a median age of 4.5 years, 66.9% were receiving cotrimoxazole prophylaxis, and 27.7% met 2006 WHO criteria for immunodeficiency by age. The median follow-up time was 11.6 months (interquartile range: 1.4; 30.7). Overall, 371 clinical events occurred in 162 children yielding to an incidence rate (IR) of 60.9/100 child-years (CY) [95% confidence interval (CI): 55.1 to 67.2]: 57% of clinical events led to outpatient care (IR: 33/100 CY), 38% to inpatient day care (IR: 22/100 CY), and 10% to hospitalization (IR: 5.9/100 CY). Further medical examinations were made allowing confirmed diagnoses in 40% of those (IR: 22.4/100 CY). Outpatient care was less common among immunodeficient children than those not (relative risk [RR] = 0.32, 95% CI: 0.18 to 0.56), in those whose main caregivers are both parents compared with those who are primarily cared for by their mother only (RR = 0.34, 95% CI: 0.15 to 0.77).
CONCLUSION: Untreated HIV-infected children require substantial inpatient and outpatient care in a context where ART is scaling up but still not available to all.

Entities:  

Mesh:

Year:  2013        PMID: 23262977      PMCID: PMC3568205          DOI: 10.1097/QAI.0b013e3182739c95

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  33 in total

1.  Models for longitudinal data: a generalized estimating equation approach.

Authors:  S L Zeger; K Y Liang; P S Albert
Journal:  Biometrics       Date:  1988-12       Impact factor: 2.571

2.  "They have already thrown away their chicken": barriers affecting participation by HIV-infected women in care and treatment programs for their infants in Blantyre, Malawi.

Authors:  Marie Collins Donahue; Queen Dube; Anna Dow; Eric Umar; Annelies Van Rie
Journal:  AIDS Care       Date:  2012-02-21

Review 3.  Diagnosis of HIV infection in children.

Authors:  K Nielsen; Y J Bryson
Journal:  Pediatr Clin North Am       Date:  2000-02       Impact factor: 3.278

4.  Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.

Authors:  C Chintu; G J Bhat; A S Walker; V Mulenga; F Sinyinza; K Lishimpi; L Farrelly; N Kaganson; A Zumla; S H Gillespie; A J Nunn; D M Gibb
Journal:  Lancet       Date:  2004 Nov 20-26       Impact factor: 79.321

5.  Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

Authors:  Philimon Gona; Russell B Van Dyke; Paige L Williams; Wayne M Dankner; Miriam C Chernoff; Sharon A Nachman; George R Seage
Journal:  JAMA       Date:  2006-07-19       Impact factor: 56.272

6.  Updated estimates of healthcare utilization and costs among perinatally HIV-infected children.

Authors:  Stephanie L Sansom; John E Anderson; Paul G Farnham; Kenneth Dominguez; Sada Soorapanth; Jill Clark; Thom Sukalac; Mary Jo Earp; Beverly Bohannon; Mary Glenn Fowler
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-01       Impact factor: 3.731

7.  A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants.

Authors:  D M Thea; M E St Louis; U Atido; K Kanjinga; B Kembo; M Matondo; T Tshiamala; C Kamenga; F Davachi; C Brown
Journal:  N Engl J Med       Date:  1993-12-02       Impact factor: 91.245

8.  Disease in children infected with HIV in Abidjan, Côte d'Ivoire.

Authors:  S B Lucas; C S Peacock; A Hounnou; K Brattegaard; K Koffi; M Hondé; J Andoh; J Bell; K M De Cock
Journal:  BMJ       Date:  1996-02-10

9.  Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.

Authors:  Veronica Mulenga; Deborah Ford; A Sarah Walker; Darlington Mwenya; James Mwansa; Frederick Sinyinza; Kennedy Lishimpi; Andrew Nunn; Stephen Gillespie; Ali Zumla; Chifumbe Chintu; Diana M Gibb
Journal:  AIDS       Date:  2007-01-02       Impact factor: 4.177

10.  Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Authors:  Besigin Tonwe-Gold; Didier K Ekouevi; Ida Viho; Clarisse Amani-Bosse; Siaka Toure; Patrick A Coffie; François Rouet; Renaud Becquet; Valériane Leroy; Wafaa M El-Sadr; Elaine J Abrams; François Dabis
Journal:  PLoS Med       Date:  2007-08       Impact factor: 11.069

View more
  3 in total

1.  Morbidity and health care resource utilization in HIV-infected children after antiretroviral therapy initiation in Côte d'Ivoire, 2004-2009.

Authors:  Sophie Desmonde; Jean-Bosco Essanin; Addi E Aka; Eugène Messou; Madeleine Amorissani-Folquet; Virginie Rondeau; Andrea Ciaranello; Valériane Leroy
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

2.  Reasons for hospitalization in HIV-infected children in West Africa.

Authors:  Fatoumata Dicko; Sophie Desmonde; Sikiratou Koumakpai; Hélène Dior-Mbodj; Fla Kouéta; Novisi Baeta; Niaboula Koné; Jocelyn Akakpo; Haby Signate Sy; Diarra Ye; Lorna Renner; Charlotte Lewden; Valériane Leroy
Journal:  J Int AIDS Soc       Date:  2014-04-22       Impact factor: 5.396

3.  Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire.

Authors:  Sophie Desmonde; Divine Avit; Junie Petit; Madeleine Amorissani Folquet; Francois Tanoh Eboua; Clarisse Amani Bosse; Evelyne Dainguy; Véronique Mea; Marguerite Timite-Konan; Sylvie Ngbeché; Andrea Ciaranello; Valeriane Leroy
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.